Help | Staff Login
2017 Regular Session
Overview
At the request of:
Chief Sponsors: Representative Nosse, Senator Taylor
Regular Sponsors:
Bill Title: Relating to inhalants; prescribing an effective date; providing for revenue raising that requires approval by a three-fifths majority.
Catchline/Summary: Imposes tax on distribution of inhalant product based on percentage of wholesale price.
Defines inhalant product as including inhalant-form nicotine but excluding cigarettes, tobacco products and cannabinoids. Requires licensing of place of business of inhalant product distributor. Establishes licensing program within Department of Revenue. Provides that licensing provisions become operative January 1, 2018. Applies to inhalant-form nicotine sold after January 1, 2018. Takes effect on 91st day following adjournment sine die.
Chapter Number:
Fiscal Impact: May Have Fiscal Impact, But No Statement Yet Issued
Revenue Impact: May Have Revenue Impact, But No Statement Yet Issued
Measure Analysis: Staff Measure Summary / Impact Statements
Current Location: In House Committee
Current Committee: House Committee On Revenue
Current Subcommittee:
Subsequent Referral(s):
Measure History
Scheduled Events